By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co., Inc., Rahway, NJ, USA.
The link you have selected will take you to a third-party website, owned and operated by AgileOne. Our company does not control, and is not responsible for, the accuracy, content, practices, or standards of the pharmatempjobs.com website and/or AgileOne.
We live in a time where cardiopulmonary disease is a leading global health challenge with more than 35 million people losing their lives to it over the past few years. With an impressive 60-year legacy of cardiovascular innovation, our hearts and minds are focused on solving the greatest remaining unmet needs for patients and pursuing cures and therapies for those who need them most. It’s a career with the most heartfelt mission—won't you join us?
Cardiovascular leaders who are making a real difference
Dean Y. Li, cardiologist and president of Merck Research Laboratories (MRL), discusses the state of fighting cardiovascular disease and our efforts that will push us to new heights to help patients improve their quality of cardiovascular and respiratory health.
“We've created a broad, promising pipeline to build on our legacy, and are deploying our unique expertise to advance innovations to people who need them.”
Opportunity to improve lives through breakthrough medicine
As science continues to advance, there are new opportunities to address the unmet needs of patients battling diseases like heart failure, PAH, thrombosis, and atherosclerosis. Are you passionate about helping people improve their cardio and respiratory health? This could be a great career opportunity for you to help improve patients’ lives on a large scale.
Growth into the next decade
We work with experts across the cardiovascular community to advance research that can help improve the lives of patients with cardiovascular risk. We’ll continue to build on our history of innovative cardiovascular & respiratory disease therapies to increase our understanding and help patients around the world. Here’s what we’re doing to help fight the cardiovascular & respiratory disease epidemic:
2021 growth in our broad, late-stage cardiovascular pipeline. With many internal advancements and vigorous business development, exceptional career opportunities may be ahead.
Anticipated mid-2030 revenue generated by our cardiovascular and pulmonary portfolio.
Number of dedicated colleagues in our state-of-the-art facility near South San Francisco—just one example of our continuing investment in cardiovascular drug discovery.
Making a heartfelt difference
Join our efforts toward cardiovascular and respiratory success.
Our R&D efforts
We’re determined to build upon our fundamental research strengths to deliver innovation to patients and physicians worldwide, expand our legacy of invention every day, and provide biomedical leadership in pharmaceutical R&D to address unmet needs and the best external science. Our therapeutic areas of focus are defined by our strongest scientific discoveries and our dedication to advance the most promising product opportunities.
Our commercial organization is driven by the impact they can make in offering hope to patients. Our teams in sales, marketing, market access, and business development work tirelessly to convert innovative science into deliverable offerings that support patients, payers, and physician’s needs. We take a customer-centric approach leveraging emerging digital technologies and data analysis to better understand our patients needs and to improve patients’ access to our medicines.
Our biggest, most effective differentiator: the strong, cohesive bond between our R&D and commercial teams that allows us to continue to fight the cardiovascular disease epidemic with everything we’ve got. Join a collaborative and innovative team of Cardiovascular & Respiratory Research & Development (MRL) and Human Health (HH) professionals in truly transformational medical science.
Voices of cardiovascular & respiratory success
What I have enjoyed most since transitioning from academic medicine to Merck is working together in cross functional teams to collaborate on the strategy and execution of clinical development plans for exciting new drugs in the cardiovascular pipeline.
This careers website is intended for Residents of the United States, Canada & Puerto Rico. Residents in other markets, please visit our MSD Careers page. Information on this site is for the purpose of presenting career opportunities at our organization and give our audience a view of our culture, diversity and growth opportunities. Our Company is an equal opportunity employer, Minority/Female/Disability/Veteran, proudly embracing diversity in all of its manifestations.